These factors contribute to the challenges in treating and predicting the outcome of cholangiocarcinoma, as evidenced by the poor prognosis and high mortality rates associated with the disease.The silencing of NCOA4 expression increased the migration and invasion of bile duct cancer cells and increased their clonogenic potential. This evidence concerns the gene NCOA4 and cholangiocarcinoma.